相关实验视频

Updated: Jun 21, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

SARS-CoV-2 核体蛋白诱导病理变化,可以通过 SUMO2 抵消

Franca Orsini¹, Marco Bosica¹, Annacarla Martucci¹

¹Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, MI, Italy.

International journal of molecular sciences

|July 13, 2024

概括

SARS-CoV-2 核体蛋白 (NCAP) 通过诱导压力颗粒中的 Tau 聚合来驱动 Tau 病理和认知障碍. SUMOylation,特别是SUMO2,可以减轻这些神经毒性影响,为COVID-19相关的神经复杂症提供潜在的治疗点.

科学领域:

神经科学是一个神经科学.
病毒学病毒学
分子生物学分子生物学

背景情况:

COVID-19 (由SARS-CoV-2引起) 可以导致直接和长期的神经问题.
脑损伤和阿尔茨海默病理学的标志物陶蛋白水平升高,在患有神经症状的COVID-19患者中观察到.
SARS-CoV-2 感染会改变神经元中的酸化和分布,但潜在的机制尚不清楚.

研究的目的:

为了调查SARS-CoV-2核体蛋白 (NCAP) 是否将Tau招募到压力颗粒 (SG) 中.
要确定NCAP是否与Tau相互作用,以及它在神经元中的SGs的局部化.
探索SUMOylation在调节NCAP-Tau相互作用和病理学的作用.

主要方法:

使用海马神经元的体外和体内研究.
调查NCAP和Tau之间的同地化和物理相互作用.
评估Tau酸化,SG形成和小鼠的认知功能.
分析SUMOylation对NCAP诱导病理学的影响.

主要成果:

发现NCAP和Tau在物理上进行局部化和互动.
在小鼠中,NCAP诱导了Tau过酸化和认知障碍.
证明SUMOylation可以调节NCAP SG的形成和认知表现.

结论:

NCAP直接诱导tau的病理变化,无论是体外还是体内.
SUMOylation,特别是SUMO2,可以改善NCAP诱导的Tau病理.
该SUMOylation途径为病毒感染和Tau病理引起的神经毒性的潜在治疗标.

关键词:

这就是SARS-CoV-2病毒.这就是所谓的SUMO.记忆记忆记忆记忆记忆核体蛋白质是核体蛋白质的一种.压力颗粒是压力颗粒.有关突触的突触.知道的知道的知道的

更多相关视频

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...